Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

The approval allows initiation of a Phase 1 first-in-human clinical trial to evaluate the safety and potential of ER-100 in patients with optic nerve disorders. The study will include individuals with ...

Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

Mineral casts of cancer cell surfaces reprogram fat cells into stem cells and improve insulin sensitivity in obese mice ...

It is well known that students who prepare in advance perform better in exams. Now, it appears that the skin can do the same.

Ageing reversal may be closer than we think – scientists have begun human trials to test anti-ageing methods.

A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...

It is well known that students who prepare in advance perform better on exams. Now, it appears that the skin can do the same.Rather than scrambling to ...

Researchers highlighted how an arginine- and proline-restricted diet combined with eflornithine reprogrammed MYCN-driven ...

HexemBio has launched with a seed round led by Draper Associates to advance a blood stem cell rejuvenation therapy backed by Robert Langer.